96 related articles for article (PubMed ID: 2213506)
1. Interferon-alpha treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1.
Yasuda Y; Miyake S; Kato S; Kita M; Kishida T; Kimura T; Ikuta K
J Acquir Immune Defic Syndr (1988); 1990; 3(11):1046-51. PubMed ID: 2213506
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
Smith MS; Thresher RJ; Pagano JS
Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
[TBL] [Abstract][Full Text] [Related]
4. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
Agy MB; Acker RL; Sherbert CH; Katze MG
Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
[TBL] [Abstract][Full Text] [Related]
5. The effect of interferon on cells persistently infected with HIV.
Crespi M
AIDS; 1989 Jan; 3(1):33-6. PubMed ID: 2496710
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon.
Ito M; Baba M; Shigeta S; De Clercq E; Walker RT; Tanaka H; Miyasaka T
Antiviral Res; 1991 May; 15(4):323-30. PubMed ID: 1683214
[TBL] [Abstract][Full Text] [Related]
7. Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.
Vendrame D; Sourisseau M; Perrin V; Schwartz O; Mammano F
J Virol; 2009 Oct; 83(20):10527-37. PubMed ID: 19706714
[TBL] [Abstract][Full Text] [Related]
8. Expression of herpes simplex virus type 1 glycoproteins in interferon-treated human neuroblastoma cells.
Chatterjee S; Burns P
J Virol; 1990 Oct; 64(10):5209-13. PubMed ID: 2168998
[TBL] [Abstract][Full Text] [Related]
9. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.
Shirazi Y; Pitha PM
J Virol; 1992 Mar; 66(3):1321-8. PubMed ID: 1738192
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
11. Effect of interferon on Vero cells persistently infected with SSPE virus and lytically infected with measles virus.
Crespi M; Chiu MN; Schoub BD; Lyons SF
Arch Virol; 1986; 90(1-2):87-96. PubMed ID: 3729726
[TBL] [Abstract][Full Text] [Related]
12. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells.
Han X; Becker K; Degen HJ; Jablonowski H; Strohmeyer G
Eur J Clin Invest; 1996 Apr; 26(4):286-92. PubMed ID: 8732485
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha.
Pagano PJ; Chong KT
J Infect Dis; 1995 Jan; 171(1):61-7. PubMed ID: 7528253
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an MT4 cell line persistently producing infective HIV-1 particles.
Gyuris A; Vajda G; Földes I
Acta Microbiol Hung; 1992; 39(3-4):271-9. PubMed ID: 1364232
[TBL] [Abstract][Full Text] [Related]
15. Restriction of HIV-1 replication in promonocytic cells: a role for IFN-alpha.
Macé K; Duc Dodon M; Gazzolo L
Virology; 1989 Feb; 168(2):399-405. PubMed ID: 2492697
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment.
Després P; Griffin JW; Griffin DE
J Virol; 1995 Nov; 69(11):7345-8. PubMed ID: 7474167
[TBL] [Abstract][Full Text] [Related]
17. Obstruction of HIV-1 particle release by interferon-alpha occurs before viral protease processing and is independent of envelope glycoprotein.
Babé LM; Unal A; Craik CS
J Interferon Cytokine Res; 1997 May; 17(5):287-93. PubMed ID: 9181467
[TBL] [Abstract][Full Text] [Related]
18. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
19. [Persistence of type 1 human immunodeficiency virus (HIV-1) in MT-4 cells in presence of alpha-interferon].
Selimova LM; Iordanskiĭ SN; Kazennova EV; Bobkov AV
Vopr Virusol; 2001; 46(2):17-20. PubMed ID: 11392964
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.
Biswas P; Poli G; Kinter AL; Justement JS; Stanley SK; Maury WJ; Bressler P; Orenstein JM; Fauci AS
J Exp Med; 1992 Sep; 176(3):739-50. PubMed ID: 1512539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
